754 related articles for article (PubMed ID: 22059858)
1. Ocular pharmacokinetics profile of different indomethacin topical formulations.
Bucolo C; Melilli B; Piazza C; Zurria M; Drago F
J Ocul Pharmacol Ther; 2011 Dec; 27(6):571-6. PubMed ID: 22059858
[TBL] [Abstract][Full Text] [Related]
2. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
Zhang L; Zhang J; Wang L; Xia H
Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
[TBL] [Abstract][Full Text] [Related]
3. Ocular pharmacokinetics of topically-applied ketoconazole solution containing hydroxypropyl beta-cyclodextrin to rabbits.
Zhang J; Wang L; Gao C; Zhang L; Xia H
J Ocul Pharmacol Ther; 2008 Oct; 24(5):501-6. PubMed ID: 18803444
[TBL] [Abstract][Full Text] [Related]
4. Vitreous and aqueous penetration of orally and topically administered moxifloxacin.
Fukuda M; Shibata N; Osada H; Yamashiro Y; Sasaki H
Ophthalmic Res; 2011; 46(3):113-7. PubMed ID: 21325873
[TBL] [Abstract][Full Text] [Related]
5. [Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery].
Hessemer V; Schmitt K; Jacobi A
Klin Monbl Augenheilkd; 1996 Mar; 208(3):161-6. PubMed ID: 8699774
[TBL] [Abstract][Full Text] [Related]
6. Preparation of 0.05% FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.
Yuan J; Zhai JJ; Chen JQ; Ye CT; Zhou SY
J Ocul Pharmacol Ther; 2009 Aug; 25(4):345-50. PubMed ID: 19492954
[TBL] [Abstract][Full Text] [Related]
7. Ocular pharmacokinetics comparison between 0.2% olopatadine and 0.77% olopatadine hydrochloride ophthalmic solutions administered to male New Zealand white rabbits.
Iyer GR; Cason MM; Womble SW; Li G; Chastain JE
J Ocul Pharmacol Ther; 2015 May; 31(4):204-10. PubMed ID: 25775192
[TBL] [Abstract][Full Text] [Related]
8. Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.
Proksch JW; Granvil CP; Siou-Mermet R; Comstock TL; Paterno MR; Ward KW
J Ocul Pharmacol Ther; 2009 Aug; 25(4):335-44. PubMed ID: 19492955
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.
Chang-Lin JE; Attar M; Acheampong AA; Robinson MR; Whitcup SM; Kuppermann BD; Welty D
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):80-6. PubMed ID: 20702826
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid.
Yamaguchi M; Ueda K; Isowaki A; Ohtori A; Takeuchi H; Ohguro N; Tojo K
Biol Pharm Bull; 2009 Jul; 32(7):1266-71. PubMed ID: 19571396
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
[TBL] [Abstract][Full Text] [Related]
13. Aqueous humor penetration of ketorolac formulated in DuraSite or DuraSite 2 delivery systems compared to Acular LS in rabbits.
Shafiee A; Bowman LM; Hou E; Hosseini K
J Ocul Pharmacol Ther; 2013 Nov; 29(9):812-6. PubMed ID: 23992042
[TBL] [Abstract][Full Text] [Related]
14. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
Zuo Z; Tam YK; Diakur J; Wiebe LI
J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
[TBL] [Abstract][Full Text] [Related]
15. Determination of the transdermal bioavailability of a newly developed diclofenac sodium patch in comparison with a reference preparation.
Gschwend MH; Martin W; Arnold P; Verdun MO; Cambon N; Frentzel A; Scheiwe W
Arzneimittelforschung; 2005; 55(7):403-13. PubMed ID: 16080280
[TBL] [Abstract][Full Text] [Related]
16. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Proksch JW; Ward KW
J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops.
Loftsson T; Hreinsdóttir D; Stefánsson E
J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution.
Chetoni P; Panichi L; Burgalassi S; Benelli U; Saettone MF
J Ocul Pharmacol Ther; 2000 Aug; 16(4):363-72. PubMed ID: 10977132
[TBL] [Abstract][Full Text] [Related]
19. A phase I study evaluating the pharmacokinetic profile of a novel, proprietary, nano-formulated, lower-dose oral indomethacin.
Manvelian G; Daniels S; Altman R
Postgrad Med; 2012 Jul; 124(4):197-205. PubMed ID: 22913908
[TBL] [Abstract][Full Text] [Related]
20. [The pharmacokinetics of FK506 and its nanoparticles in aqueous humor of rabbits].
Fei WL; Chen JQ; Zhong SL; Liu YM; Pang ZQ; Wang Z; Yuan J; Ye CT
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):305-8. PubMed ID: 16762205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]